Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20315)

• Formulation Name: Sorafenib 200 mg tablet
• Company: Bayer HealthCare

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Sorafenib	(DMS8IFC)	Adenocarcinoma	2D40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Eisenoxyd	(E00585)	56841934	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent